Similar articles for PMID: 35220264

Year	Number of Results
1990	1
1993	1
1995	4
1997	2
1998	3
1999	3
2000	3
2001	1
2002	2
2003	4
2004	6
2005	3
2006	1
2007	6
2008	3
2009	4
2010	6
2011	4
2012	6
2013	6
2014	9
2015	4
2016	3
2017	2
2018	2
2019	3
2020	4
2021	2
2022	4
2024	0

1

Highly Advanced Colorectal Liver Metastases Successfully Treated With Fluorouracil Plus Leucovorin Monotherapy and Microwave Ablation.

Matsumura K, Yamamura K, Miyamoto H, Hara Y, Oda E, Akahoshi S, Yoshida K, Yuki H, Motohara T, Sakamoto K, Komohara Y, Beppu T. Matsumura K, et al. Anticancer Res. 2022 Mar;42(3):1645-1651. doi: 10.21873/anticanres.15641. Anticancer Res. 2022. PMID: 35220264

2

The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.

Hokuto D, Nomi T, Yamato I, Yasuda S, Obara S, Yoshikawa T, Kawaguchi C, Yamada T, Kanehiro H, Nakajima Y. Hokuto D, et al. J Surg Oncol. 2016 Dec;114(8):959-965. doi: 10.1002/jso.24461. Epub 2016 Sep 28. J Surg Oncol. 2016. PMID: 27683191

3

Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy.

Adachi Y, Yamamura K, Yumoto S, Higashi T, Ishiodori H, Honda S, Hara Y, Matsumura K, Oda E, Akahoshi S, Yuki H, Miyamoto H, Doi K, Beppu T. Adachi Y, et al. Anticancer Res. 2021 Nov;41(11):5855-5861. doi: 10.21873/anticanres.15405. Anticancer Res. 2021. PMID: 34732462

4

Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases.

Miller CL, Taylor MS, Qadan M, Deshpande V, Worthington S, Smalley R, Collura C, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Parikh AR, Berger D, Tanabe KK, Lillemoe KD, Ferrone CR. Miller CL, et al. J Gastrointest Surg. 2017 Nov;21(11):1831-1840. doi: 10.1007/s11605-017-3557-0. Epub 2017 Sep 7. J Gastrointest Surg. 2017. PMID: 28884391

5

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).

Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D. Goéré D, et al. BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7. BMC Cancer. 2018. PMID: 30081865 Free PMC article.

6

Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.

Toyama Y, Ushigome T, Watanabe K, Kitamura H, Onda S, Saito R, Yoshida S, Kawahara H, Yanagisawa S, Yanaga K. Toyama Y, et al. World J Surg Oncol. 2012 Jun 29;10:129. doi: 10.1186/1477-7819-10-129. World J Surg Oncol. 2012. PMID: 22747970 Free PMC article.

7

The actual management of colorectal liver metastases.

Pérez-Santiago L, Dorcaratto D, Garcés-Albir M, Muñoz-Forner E, Huerta Álvaro M, Roselló Keranën S, Sabater L. Pérez-Santiago L, et al. Minerva Chir. 2020 Oct;75(5):328-344. doi: 10.23736/S0026-4733.20.08436-9. Epub 2020 Aug 6. Minerva Chir. 2020. PMID: 32773753 Review.

8

Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis.

Ji JH, Park SH, Lee J, Kim TW, Hong YS, Kim KP, Kim SY, Baek JY, Kang HJ, Shin SJ, Shim BY, Park YS. Ji JH, et al. Cancer Chemother Pharmacol. 2013 Jul;72(1):223-30. doi: 10.1007/s00280-013-2190-1. Epub 2013 May 21. Cancer Chemother Pharmacol. 2013. PMID: 23689915 Clinical Trial.

9

Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.

Baba K, Oshita A, Kohyama M, Inoue S, Kuroo Y, Yamaguchi T, Nakamura H, Sugiyama Y, Tazaki T, Sasaki M, Imamura Y, Daimaru Y, Ohdan H, Nakamitsu A. Baba K, et al. World J Gastroenterol. 2015 Feb 14;21(6):1982-8. doi: 10.3748/wjg.v21.i6.1982. World J Gastroenterol. 2015. PMID: 25684967 Free PMC article.

10

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK).

Borner MM, Castiglione M, Bacchi M, Weber W, Herrmann R, Fey MF, Pagani O, Leyvraz S, Morant R, Pestalozzi B, Hanselmann S, Goldhirsch A. Borner MM, et al. Ann Oncol. 1998 May;9(5):535-41. doi: 10.1023/a:1008270916325. Ann Oncol. 1998. PMID: 9653495 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year